Summary

Market Overview
Lateral flow assays are devices that may be used to confirm the presence or absence of a target analyte without using lab equipment. For the qualitative and quantitative detection of particular antigens and antibodies, these instruments are frequently employed in hospitals and clinical laboratories. It's a low-cost, straightforward method for detecting infections or biomarkers in humans and animals, as well as pollutants and harmful substances in water, food, and animal feed. The COVID-19 pandemic has had a beneficial influence on the lateral flow assays market, since the requirement for quick identification of coronavirus infection has been a priority since the epidemic began in December 2019. As the number of cases has grown across the globe, most of the major lateral flow assay market players have invested in research and development, and formed partnerships and agreements with other market players and government agencies to develop lateral flow diagnostic solutions for the disease. As a result, several COVID-19 antibody and antigen tests have been launched, with excess manufacturing and distribution of these tests across areas to meet increased demand.

Lateral Flow Assays Market: Key Players
Abbott Laboratories (U.S.)

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Siemens Healthineers AG (Germany)
Becton, Dickinson and Company (U.S.)
BioMérieux SA (France)
Bio-Rad Laboratories Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
QIAGEN N.V. (Germany)
PerkinElmer Inc. (U.S.)
Quidel Corporation (U.S.)
Merck KGAA (Germany)


Growth Factor
High prevalence of infectious diseases across the globe
Despite tremendous advancements in sanitation and medicine, infectious illness incidence remains high over the world. Infectious illnesses are still a major public health problem across the world, despite the fact that non-communicable illnesses are the largest cause of morbidity and mortality. Infectious illnesses take the lives of more than 15 million people worldwide each year, according to the National Institute of Allergy and Infectious Diseases. In the forecast period, this factor is expected to be a significant driver of the lateral flow assays market.

Segmentation
By Product
Kits & Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
By Technique
Sandwich Assays
Competitive Assays
Multiplex Detection Assays
By Application
Clinical Testing
Infectious Disease Testing
Cardiac Marker Testing
Pregnancy & Fertility Testing
Cholesterol Testing/Lipid Profile
Drug Abuse Testing
Other Clinical Tests
Veterinary Diagnostics
Food Safety & Environment Testing
Drug Development & Quality Testing
By End-User
Hospitals & Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical & Biotechnology Companies
Other End Users
Lateral Flow Assays Market Dynamics
Lateral Flow Assays Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints


Recent News Related to Market
In September 2020, the PanBio COVID-19 immunochromatographic test for quick qualitative identification of Sars-CoV-2 virus was introduced in Europe by Abbott Laboratories (US).

In September 2020, F.Hoffman La Roche Ltd. (Switzerland) will offer the SARS CoV-2 Rapid Antigen Test in markets that accept the CE Mark.



The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Lateral Flow Assays Market growth?
Which segment accounted for the largest Lateral Flow Assays Market share?
Who are the key players in the Lateral Flow Assays Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint


Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

ページTOPに戻る

Table of Contents

Contents
1. Executive Summary
2. Global Lateral Flow Assays Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Lateral Flow Assays Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Lateral Flow Assays Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Lateral Flow Assays Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Kits and Reagents, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Lateral Flow Readers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Digital/Mobile Readers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Benchtop Readers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technique: Market Share (2020-2030F)
12.3.1. Sandwich Assays, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Competitive Assays, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Multiplex Detection Assays, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Clinical Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Infectious Disease Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Cardiac Marker Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Pregnancy & Fertility Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Cholesterol Testing/Lipid Profile, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.6. Drug Abuse Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.7. Other Clinical Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.8. Veterinary Diagnostics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.9. Food Safety & Environment Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.10. Drug Development & Quality Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospitals & Clinics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Diagnostic Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Home Care, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Pharmaceutical & Biotechnology Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Abbott Laboratories (U.S)
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Danaher Corporation (U.S.)
13.3. F. Hoffmann-La Roche Ltd. (Switzerland)
13.4. Siemens Healthineers AG (Germany)
13.5. Becton, Dickinson and Company (U.S.)
13.6. BioMérieux SA (France)
13.7. Bio-Rad Laboratories Inc. (U.S.)
13.8. Thermo Fisher Scientific Inc. (U.S.)
13.9. QIAGEN N.V. (Germany)
13.10. PerkinElmer Inc. (U.S.)
13.11. Quidel Corporation (U.S.)
13.12. Merck KGAA (Germany)
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.